- Home
- KLRS vs CNTY Comparison
KLRS vs CNTY Comparison
Compare KLRS & CNTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KLRS | CNTY |
|---|---|---|
| Founded | 2019 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.0M | 45.1M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | KLRS | CNTY |
|---|---|---|
| Price | $8.76 | $1.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $20.67 | $3.67 |
| AVG Volume (30 Days) | ★ 55.5K | 28.6K |
| Earning Date | 01-01-0001 | 06-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $430,529,000.00 |
| Revenue This Year | N/A | $2.20 |
| Revenue Next Year | N/A | $7.18 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.82 |
| 52 Week Low | $2.14 | $1.23 |
| 52 Week High | $11.90 | $2.85 |
Technical Indicators
Market Signals| Indicator | KLRS | CNTY |
|---|---|---|
| Relative Strength Index (RSI) | 40.73 | 30.72 |
| Support Level | $8.27 | $1.23 |
| Resistance Level | $8.80 | $1.51 |
| Average True Range (ATR) | 0.83 | 0.10 |
| MACD | -0.18 | -0.03 |
| Stochastic Oscillator | 0.00 | 18.20 |
Price Performance
Historical ComparisonAbout KLRS Kalaris Therapeutics Inc.
Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases. The company is developing TH103, a novel, clinical-stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer-lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body's native, highest affinity VEGF receptor 1.
About CNTY Century Casinos Inc.
Century Casinos Inc is a casino entertainment company that develops and operates gaming establishments as well as related lodging, restaurants, horse racing (including off-track betting), and entertainment facilities in North America. The company has three reportable segments based on the geographical locations in which its casinos operate; United States; Century Casino & Hotel-Central City, and Century Casino & Hotel-Cripple Creek in Colorado, Mountaineer Casino, Racetrack & Resort in West Virginia, and Century Casino Caruthersville, and Century Casino Cape Girardeau in Missouri, Canada; Century Casino & Hotel, Century Casino St. Albert, Century Mile Racetrack in Edmonton and Casino Century Downs Racetrack and Casino in Calgary, and Poland; Casinos Poland.